Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of Vancomycin Treatment of Infections Due to Staphylococcus Aureus

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: OTHER
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* 19 years of age or older~* Admitted to an inpatient care unit at The Nebraska Medical Center~* Prescribed intravenous vancomycin therapy with a dosing interval of 24 hours or less~* Vancomycin therapy that lasts for at least 3 doses or 5 half-lives as scheduled with no dosage changes~Exclusion Criteria:~* Estimated creatinine clearance (CrCl) less than 30 ml/min using the Cockroft-Gault equation (in patients over the age of 65 a SCr of 1.0 mg/dL will be assumed for all patients with a reported SCr less than 1.0 mg/dL). Ideal body weight will be used for the Cockroft-Gault equation unless the actual body weight is less than the ideal body weight.~* Patients requiring any form of dialysis~* Pregnancy

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).